The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Onyx Biotec IPO
Onyx Biotec
SMEListed

Onyx Biotec IPO

Bidding 13-18 Nov 2024, price band ₹58–61, lot 2000 shares.

OverviewAllotment

IPO timeline

  1. Issue open date
    13 Nov 2024
  2. Issue close date
    18 Nov 2024
  3. UPI mandate deadline
    18 Nov 2024
  4. Allotment finalization
    19 Nov 2024
  5. Refund initiation
    20 Nov 2024
  6. Share credit
    20 Nov 2024
  7. Listing date
    21 Nov 2024
  8. Mandate end date
    2 Dec 2024
  9. Lock-in end date for anchor investors (50%)
    19 Dec 2024
  10. Lock-in end date for anchor investors (remaining)
    17 Feb 2025

Onyx Biotec IPO Allotment Status

Allotment date:19 Nov 2024
Registrar:Mas Services Limited
  1. Open the registrar's allotment page from the link below.
  2. Select Onyx Biotec from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on Mas Services(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:20 Nov 2024
Shares credited to demat:20 Nov 2024
Listing:21 Nov 2024

Quick Stats

Issue Size:29cr
Lot Size:2000 shares
Min Investment (2 lots):₹2,44,000

Price Band

₹58–61
per share

About the Company

Onyx Biotec Limited, established in 2005 and converted to a public company in 2024, specializes in manufacturing sterile pharmaceutical products like sterile water for injections and dry powder injections, serving top pharma clients across India and overseas. With two manufacturing facilities in Himachal Pradesh accredited by WHO-GMP, the company follows strict quality controls and sustainable practices. It plans to enhance Unit I for large-volume parental production and Unit II with a high-speed packaging line, improving operational efficiency and cost. Led by experienced promoters, Onyx is committed to delivering affordable, high-quality healthcare solutions, maintaining strong client relationships, and adhering to ISO and GMP standards to ensure quality, safety, and customer satisfaction.

Strengths

  • Leading contract manufacturer specializing in sterile pharmaceutical production.
  • Rigorous Quality Assurance and Quality Control processes ensure high product standards.
  • Established, long-term relationships with top-tier clients in the pharmaceutical industry.
  • Cost-efficient production processes with a focus on timely order fulfilment.
  • Experienced management team with strong project management and implementation expertise.

Risks

  • Region-specific risks in Solan, Himachal Pradesh could impact operations.
  • Manufacturing disruptions could harm financial health and cash flow.
  • Reliance on third-party suppliers risks supply delays or shortages.
  • Heavy dependence on key clients makes revenue vulnerable to client loss.
  • Pharmaceutical industry downturns could reduce demand for products.
  • Quality or delivery issues may lead to order cancellations and financial loss.

Onyx Biotec IPO – Frequently Asked Questions

  • The price band for the Onyx Biotec IPO is set at ₹58 to ₹61 per share.
  • The Onyx Biotec IPO opens on November 13, 2024 and closes on November 18, 2024.
  • The tentative listing date for the Onyx Biotec IPO is November 21, 2024.
  • The Onyx Biotec IPO allotment date is November 19, 2024. Once it is finalised, check your status with your PAN or application number on the website of the registrar, Mas Services Limited. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Onyx Biotec IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Onyx Biotec, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Onyx Biotec IPO is 2000 shares. As an SME IPO, individual investors must apply for at least 2 lots (i.e., 4000 shares), which costs ₹2,44,000 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent SME listings

  • Antala IndustriesListed 11 Nov 2026
    -20%
  • Vedant Poly FabsListed 9 Nov 2026
    0%
  • Johnsoncab ElectricalsListed 6 Nov 2026
    +19.25%
  • HGS (India)Listed 6 Nov 2026
    +33.33%
  • Vectras EnproconListed 6 Nov 2026
    +0.95%
  • Maxwell Engineering SolutionsListed 6 Nov 2026
    +90%

All IPOs that opened in November 2024